DOI QR코드

DOI QR Code

Evolution of Interferon-Gamma Release Assay Results and Submillisievert Chest CT Findings among Close Contacts of Active Pulmonary Tuberculosis Patients

  • Yoon, Soonho (Department of Radiology, Seoul National University Hospital, Seoul National University College of Medicine) ;
  • Mihn, Do-CiC (Seegene Medical Foundation) ;
  • Song, Jin-Wha (Department of Internal Medicine, Veterans Health Service Medical Center) ;
  • Kim, Sung A (Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul National University College of Medicine) ;
  • Yim, Jae-Joon (Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul National University College of Medicine)
  • Received : 2020.04.15
  • Accepted : 2020.07.07
  • Published : 2020.10.31

Abstract

Background: Latent tuberculosis (TB) infection among TB contacts is diagnosed using plain chest radiography and interferon-gamma release assays (IGRAs). However, plain chest radiographs often miss active TB, and the results of IGRA could fluctuate over time. The purpose of this study was to elucidate changes in the results of the serial IGRAs and in the findings of the serial submillisievert chest computed tomography (CT) scans among the close contacts of active pulmonary TB patients. Methods: Patients age 20 or older with active pulmonary TB and their close contacts were invited to participate in this study. Two types of IGRA (QuantiFERON-TB Gold In-Tube assay [QFT-GIT] and the T-SPOT.TB test [T-SPOT]) and submillisievert chest CT scanning were performed at baseline and at 3 and 12 months after enrollment. Results: In total, 19 close contacts participated in this study. One was diagnosed with active pulmonary TB and was excluded from further analysis. At baseline, four of 18 contacts (22.2%) showed positive results for QFT-GIT and T-SPOT; there were no discordant results. During the follow-up, transient and permanent positive or negative conversions and discordant results between the two types of IGRAs were observed in some patients. Among the 17 contacts who underwent submillisievert chest CT scanning, calcified nodules were identified in seven (41.2%), noncalcified nodules in 14 (82.4%), and bronchiectasis in four (23.5%). Some nodules disappeared over time. Conclusion: The results of the QFT-GIT and T-SPOT assays and the CT images may change during 1 year of observation of close contacts of the active TB patients.

Keywords

References

  1. World Health Organization. Global tuberculosis report 2019. WHO/CDS/TB/2019.15 [Internet]. Geneva: World Health Organization; 2019. Available from: https://apps.who.int/iris/bitstream/handle/10665/329368/9789241565714-eng.pdf.
  2. Getahun H, Matteelli A, Chaisson RE, Raviglione M. Latent Mycobacterium tuberculosis infection. N Engl J Med 2015;372:2127-35. https://doi.org/10.1056/NEJMra1405427
  3. Joint Committee for the Revision of Korean Guidelines for Tuberculosis, Korea Centers for Disease Control and Prevention. Korean guidelines for tuberculosis. 3rd ed. Seoul: Korean Academy of Tuberculosis and Respiratory Diseases; 2017.
  4. Lee SW, Jang YS, Park CM, Kang HY, Koh WJ, Yim JJ, et al. The role of chest CT scanning in TB outbreak investigation. Chest 2010;137:1057-64. https://doi.org/10.1378/chest.09-1513
  5. Park JS, Lee JS, Kim MY, Lee CH, Yoon HI, Lee SM, et al. Monthly follow-ups of interferon-gamma release assays among health-care workers in contact with patients with TB. Chest 2012;142:1461-8. https://doi.org/10.1378/chest.11-3299
  6. QuantiFERON-TB Gold In Tube test. ELISA package insert. Hilden: Qiagen; 2016.
  7. T-SPOT.TB, blood test package insert. Oxford: Oxford Immunotec; 2017.
  8. Deak PD, Smal Y, Kalender WA. Multisection CT protocols: sex- and age-specific conversion factors used to determine effective dose from dose-length product. Radiology 2010;257:158-66. https://doi.org/10.1148/radiol.10100047
  9. Arend SM, Thijsen SF, Leyten EM, Bouwman JJ, Franken WP, Koster BF, et al. Comparison of two interferon-gamma assays and tuberculin skin test for tracing tuberculosis contacts. Am J Respir Crit Care Med 2007;175:618-27. https://doi.org/10.1164/rccm.200608-1099OC
  10. Lee JY, Choi HJ, Park IN, Hong SB, Oh YM, Lim CM, et al. Comparison of two commercial interferon-gamma assays for diagnosing Mycobacterium tuberculosis infection. Eur Respir J 2006;28:24-30. https://doi.org/10.1183/09031936.06.00016906
  11. Bae W, Park KU, Song EY, Kim SJ, Lee YJ, Park JS, et al. Comparison of the sensitivity of QuantiFERON-TB Gold In- Tube and T-SPOT.TB according to patient age. PLoS One 2016;11:e0156917. https://doi.org/10.1371/journal.pone.0156917
  12. Joshi M, Monson TP, Joshi A, Woods GL. IFN-gamma release assay conversions and reversions: challenges with serial testing in U.S. health care workers. Ann Am Thorac Soc 2014;11:296-302. https://doi.org/10.1513/annalsats.201310-378oc
  13. Lee SC, Yoon SH, Goo JM, Yim JJ, Kim CK. Submillisievert computed tomography of the chest in contact investigation for drug-resistant tuberculosis. J Korean Med Sci 2017;32:1779-83. https://doi.org/10.3346/jkms.2017.32.11.1779
  14. Lyu J, Lee SG, Hwang S, Lee SO, Cho OH, Chae EJ, et al. Chest computed tomography is more likely to show latent tuberculosis foci than simple chest radiography in liver transplant candidates. Liver Transpl 2011;17:963-8. https://doi.org/10.1002/lt.22319